How to Profit From Biotech Merger ManiaBy William Patalon III, Executive Editor, Money Morning • July 2, 2013Start the conversationLeave a Reply Click here to cancel reply.Your email address will not be published. Required fields are marked *Name * Email * Website − two = 6 Comment Some HTML is OK Sign me up for the Money Morning newsletter William Patalon IIIIn early January, we told you that Big Pharma players were starting the New Year with $70 billion in cash on their balance sheets - meaning the "buyout binge" that started in 2012 was certain to carry over into 2013.And that's just what's happened.Faced with patent expirations on existing blockbuster drugs, and pipelines that are bereft of replacements, Big Pharma players have been all year long to buy companies outright, to buy product lines or R&D portfolios, or just to purchase individual drugs.To continue reading, please click here...This is premium content for Private Briefing subscribers only. As the executive editor of Money Morning, Bill Patalon has perfected a secret investment strategy that could help you put an extra $125K into your portfolio - this year. To date, Bill has used this strategy to pick 257 winning investments, including 192 double- and triple-digit peak gains. Once you see the secret, you'll immediately understand why it works so well.